Details of the Drug

General Information of Drug (ID: DMILKZ6)

Drug Name

TAK-583

Indication

Disease Entry	ICD 11	Status	REF
Diabetic neuropathy	8C0Z	Phase 2/3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00377598) Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia. U.S. National Institutes of Health.